Retatrutide Peptide
Retatrutide is a triple-receptor agonist peptide targeting GIP, GLP-1, and glucagon receptors to support appetite regulation, glucose metabolism, and energy expenditure. In a phase 2 obesity study, it produced a mean 24.2% body-weight reduction after 48 weeks, while phase 3 trials continue to evaluate its safety and efficacy.
Specifications
- Size
- 5mg Pre-Filled Pen (SubQ), 10mg Pre-Filled Pen (SubQ)
Variants (2)
- 5mg Pre-Filled Pen (SubQ) — 799.00 ZAR — In stock
- 10mg Pre-Filled Pen (SubQ) — 1359.00 ZAR — Out of stock
How AI sees this product
The more complete this product's details, the more confidently AI assistants can understand and recommend it.
80%